Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

NCT03160079

Conditions
B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • UCSF Fresno Community Cancer Institute Clovis, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View Trial Details
Completed

A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

NCT02875548

Conditions
Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
  • Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 34 locations
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

NCT04875195

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
  • Tulane Medical Center ( Site 0110) New Orleans, Louisiana, United States
  • Anne Arundel Medical Center-Anne Arundel Oncology and Hematology ( Site 0125) Annapolis, Maryland, United States
  • Hospital Erasto Gaertner ( Site 1703) Curitiba, Paraná, Brazil
View all 27 locations
View Trial Details
Completed

Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

NCT00310037

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Illinois CancerCare - Bloomington Bloomington, Illinois, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
  • Graham Hospital Canton, Illinois, United States
View all 48 locations
View Trial Details
Completed

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

NCT05075603

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center Detroit, Michigan, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Duke Cancer Institute Durham, North Carolina, United States
View Trial Details
Completed

ASP8374 + Cemiplimab in Recurrent Glioma

NCT04826393

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Hospital of the University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NCT01592370

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Local Institution - 0035 Clovis, California, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0017 Aurora, Colorado, United States
View all 43 locations
View Trial Details

Related conditions